COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Biotechnology Annual Review - 1st Edition - ISBN: 9780444517494, 9780080930886

Biotechnology Annual Review, Volume 10

1st Edition

Author: M. Raafat El-Gewely
Hardcover ISBN: 9780444517494
eBook ISBN: 9780080930886
Imprint: Elsevier Science
Published Date: 30th October 2004
Page Count: 322
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

Foreword - What is Biotechnology Today? (Leroy Hood, The Institute for Systems Biology, Seattle, WA, USA)

  1. Rapid translation system: a novel cell-free way from gene to protein (M. Hoffmann, C. Nemetz).
  2. Protein expression and refolding - a practical guide to getting the most out of inclusion bodies (L.D. Cabrita, S. Bottomley).
  3. Towards a systems biology understanding of human health: interplay between genotype, environment and nutrition.
  4. Public health issues related with the consumption of food obtained from genetically modified organisms (A. Paparini, V. Romano-Spica).
  5. p75 neurotrophin receptor signaling in the nervous system (Y. Hasegawa et al.).
  6. Phage display for epitope determination: a paradigm for identifying receptor-ligand interactions (M.J. Rowley, K. O'Connor, L. Wijeyewickrema).
  7. DNA vaccines and their application against parasites - promise, limitations and potential solutions (P.M. Smooker et al.).
  8. Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge (R. Smalling et al.).
  9. Using the biologic license application or new drug application as a basis for the common technical document (M. Foote).
  10. Guidelines and policies for medical writers in the biotech industry: an update on the controversy (M. Foote).
  11. Radioimmunotherapy of Non-Hodgkin's lymphoma: clinical development of the zevalin regimen (C.P. Theuer et al.).
  12. Biosimulation software is changing research (R.L.X. Ho, L.T. Bartsell).


No. of pages:
© Elsevier Science 2005
30th October 2004
Elsevier Science
Hardcover ISBN:
eBook ISBN:

Ratings and Reviews

About the Author

M. Raafat El-Gewely

Affiliations and Expertise

Department of Biotechnology, Institute of Medical Biology, University of Tromso, Norway